Free Newsletter
New advances on hypertension
Researchers at the University of Bristol say that they've found a protein--JAM-1--in the walls of the blood vessels in the brain that may be directly linked to high blood pressure. The protein traps white blood cells, a process that can lead to inflammation and obstruct blood flow. And that has led the researchers to the novel conclusion that high blood pressure could be a vascular disease of the brain. About six of every 10 patients being treated for high blood pressure remain hypertensive, leading researchers to scramble for new drug targets to treat the disease.
"We are looking at the possibility of treating those patients that fail to respond to conventional therapy for hypertension with drugs that reduce blood vessel inflammation and increase blood flow within the brain," said team leader Professor Julian Paton. "The future challenge will be to understand the type of inflammation within the vessels in the brain, so that we know what drug to use, and how to target them. JAM-1 could provide us with new clues as to how to deal with this disease."
- check out the release on the findings
Comments
For years i was suffering high levels of pain
in the legs while walking and at rest.
So was taking codeine based medication for a good
number of years.
My hypertension became a problem then i was diagnosed with hereditary motor sensory peripheral nueropathy.
my medication was changed and i was taken off
codeine and put on to gabapentin (now pregablin
and tramadol).
My hypertension went soon after stopping codeine
and has been normal for the last two years.
I hope this is of help to somebody
kind regards
stephen
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: